Literature DB >> 4981514

Binding between components of the tubercle bacillus and humoral antibodies.

P Minden, R S Farr.   

Abstract

Studies were undertaken to find a substance or substances for use in primary binding types of tests to detect humoral antibodies in rabbits and monkeys exposed to the tubercle bacillus that would distinguish between strains of mycobacteria. The antigen employed was a component of the 5159 strain of Mycobacterium tuberculosis that was obtained following sonification, ultracentrifugation, electrophoresis, and elution from a preparative polyacrylamide column. When the antigen was labeled with (131)I, specific binding was observed in sera from immunized rabbits and BCG-protected rhesus monkeys by the radio-gel electrophoresis and ammonium sulfate tests. This component was partially characterized, and its major antigenic determinants were associated with anionic mucopolysaccharides. Electrophoretically at pH 8.3 it migrated anodally to albumin, its molecular weight was between 9,000 and 12,000, and it was soluble in 50% saturated ammonium sulfate. Binding to antibody was destroyed after treatment with Pronase, but not after DNase or RNase. Inhibition of the reaction, as measured by the ammonium sulfate test, between the (131)I-labeled component and antisera from rabbits that had been immunized with sonicated 5159 organisms, was studied. These experiments demonstrated a capacity to define subtle similarities and differences among different mycobacteria and mycobacterial components. Some microorganisms not clearly related to mycobacteria also partially inhibited this reaction, suggesting that they shared antigenic groups with the component derived from 5159 organisms. The studies described suggested the advisability of using direct primary tests and purified components of mycobacteria to differentiate further the antigenic groups between individual pathogenic mycobacteria and between pathogenic and nonpathogenic organisms.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4981514      PMCID: PMC2180479          DOI: 10.1084/jem.130.5.931

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  IMPROVED METHOD FOR THE ISOLATION AND PROPERTIES OF TUBERCULIN ACTIVE PEPTIDES.

Authors:  Y OKADA; S MORISAWA; K SYOJIMA; M KITAGAWA; S NAKASHIMA; Y YAMAMURA
Journal:  J Biochem       Date:  1963-12       Impact factor: 3.387

2.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  Tubercle bacillary extracts immunogenic for mice. 1. Factors affecting demonstration of their activity.

Authors:  A J CROWLE
Journal:  Tubercle       Date:  1961-12

4.  The binding capacity of tuberculous and nontuberculous human serum for I-131-labeled extracts from tubercle bacilli.

Authors:  R S FARR; H BLOCH
Journal:  Am Rev Respir Dis       Date:  1960-11

5.  The elimination of heterologous serum proteins and associated antibody responses in guinea pigs and rats.

Authors:  W O WEIGLE; F J DIXON
Journal:  J Immunol       Date:  1957-07       Impact factor: 5.422

6.  The isolation of three different proteins and two polysaccharides from tuberculin by alcohol fractionation; their chemical and biological properties.

Authors:  F B SEIBERT
Journal:  Am Rev Tuberc       Date:  1949-01

7.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

8.  Isolation, purification, and characterization of extracellular antigens of Mycobacterium tuberculosis.

Authors:  M Yoneda; Y Fukui
Journal:  Am Rev Respir Dis       Date:  1965-12

9.  Studies on the binding between streptococcal M protein and antibody.

Authors:  H M GREY
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins.

Authors:  R J DUBOS; R W SCHAEDLER
Journal:  J Exp Med       Date:  1956-07-01       Impact factor: 14.307

View more
  12 in total

1.  Immunological method to differentiate between antigens of tubercle bacilli, other mycobacterial species, and non-acid-fast bacteria.

Authors:  H R Ferguson; J K McClatchy; T R Sharpton; P Minden
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

2.  Shared antigens between heterologous bacterial species.

Authors:  P Minden; J K McClatchy; R S Farr
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

3.  Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3.

Authors:  J B Robbins; L Myerowitz; J K Whisnant; M Argaman; R Schneerson; Z T Handzel; E C Gotschlich
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

Review 4.  Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties.

Authors:  T M Daniel; B W Janicki
Journal:  Microbiol Rev       Date:  1978-03

5.  Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals.

Authors:  E J Bardana; J K McClatchy; R S Farr; P Minden
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

6.  Immunological distinction of mycobacterial beta-lactamases.

Authors:  J S Thompson; C D Severson; N A Stearns; J E Kasik
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

7.  Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG.

Authors:  P Minden; P J Kelleher; J H Freed; L D Nielsen; P J Brennan; L McPheron; J K McClatchy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans.

Authors:  J M Jones
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

9.  Antigenic Differences Between Mycobacterium bovis Strain BCG and an Isoniazid-Resistant Mutant.

Authors:  P Minden; J K McClatchy; E J Bardana; R S Farr
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

10.  Adjuvant and mitogenic properties of a supernatant fraction of sonically treated Myobacterium bovis (BCG).

Authors:  L A Baker; T Sharpton; P Minden; P A Campbell
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.